Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,162
Total Claims
$784K
Drug Cost
751
Beneficiaries
$1,044
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-37%
Opioid rate vs peers
1.6% vs 2.6% avg
-2%
Cost per patient vs peers
$1,044 vs $1,068 avg
+27%
Brand preference vs peers
11.4% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.6%
Opioid Rate
148
Opioid Claims
$1,902
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,044 claims · $602K
Generic: 8,079 claims · $180K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 82 | $91K |
| Insulin Glargine,hum.Rec.Anlog | 61 | $64K |
| Semaglutide | 45 | $59K |
| Rivaroxaban | 38 | $50K |
| Sitagliptin Phosphate | 36 | $35K |
| Insulin Aspart | 30 | $32K |
| Insulin Lispro | 27 | $28K |
| Tirzepatide | 19 | $23K |
| Tiotropium Bromide | 13 | $13K |
| Budesonide/Formoterol Fumarate | 17 | $12K |
| Fluticasone/Umeclidin/Vilanter | 17 | $11K |
| Insulin Lispro | 12 | $11K |
| Fluticasone Propion/Salmeterol | 29 | $10K |
| Levothyroxine Sodium | 461 | $9,909 |
| Atorvastatin Calcium | 605 | $8,200 |
Prescribing Profile
Patient Profile
75
Avg Age
47%
Female
1.06
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About